JNJ
Price
$151.10
Change
-$2.14 (-1.40%)
Updated
Nov 14, 11:47 AM (EDT)
75 days until earnings call
LLY
Price
$811.81
Change
-$7.05 (-0.86%)
Updated
Nov 13 closing price
77 days until earnings call
Ad is loading...

JNJ vs LLY

Header iconJNJ vs LLY Comparison
Open Charts JNJ vs LLYBanner chart's image
Johnson & Johnson
Price$151.10
Change-$2.14 (-1.40%)
Volume$9.06K
CapitalizationN/A
Eli Lilly & Co
Price$811.81
Change-$7.05 (-0.86%)
Volume$3.06M
CapitalizationN/A
JNJ vs LLY Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
JNJ vs. LLY commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and LLY is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (JNJ: $153.24 vs. LLY: $811.81)
Brand notoriety: JNJ and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 115% vs. LLY: 92%
Market capitalization -- JNJ: $380.22B vs. LLY: $739.66B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileLLY’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • LLY’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 4 TA indicator(s) are bullish while LLY’s TA Score has 4 bullish TA indicator(s).

  • JNJ’s TA Score: 4 bullish, 6 bearish.
  • LLY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LLY is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -2.94% price change this week, while LLY (@Pharmaceuticals: Major) price change was +4.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.82%. For the same industry, the average monthly price growth was -4.93%, and the average quarterly price growth was +3.33%.

Reported Earning Dates

JNJ is expected to report earnings on Jan 28, 2025.

LLY is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-3.82% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than JNJ($380B). LLY has higher P/E ratio than JNJ: LLY (131.13) vs JNJ (30.34). LLY YTD gains are higher at: 39.943 vs. JNJ (0.059). JNJ has higher annual earnings (EBITDA): 23.3B vs. LLY (8.57B). JNJ has more cash in the bank: 22.9B vs. LLY (2.93B). LLY has less debt than JNJ: LLY (25.2B) vs JNJ (29.3B). JNJ has higher revenues than LLY: JNJ (85.2B) vs LLY (34.1B).
JNJLLYJNJ / LLY
Capitalization380B740B51%
EBITDA23.3B8.57B272%
Gain YTD0.05939.9430%
P/E Ratio30.34131.1323%
Revenue85.2B34.1B250%
Total Cash22.9B2.93B782%
Total Debt29.3B25.2B116%
FUNDAMENTALS RATINGS
JNJ vs LLY: Fundamental Ratings
JNJ
LLY
OUTLOOK RATING
1..100
6559
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
304
SMR RATING
1..100
4617
PRICE GROWTH RATING
1..100
5858
P/E GROWTH RATING
1..100
7785
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (13) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (91). This means that JNJ’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as JNJ (30). This means that LLY’s stock grew similarly to JNJ’s over the last 12 months.

LLY's SMR Rating (17) in the Pharmaceuticals Major industry is in the same range as JNJ (46). This means that LLY’s stock grew similarly to JNJ’s over the last 12 months.

LLY's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as JNJ (58). This means that LLY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (77) in the Pharmaceuticals Major industry is in the same range as LLY (85). This means that JNJ’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJLLY
RSI
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
59%
MACD
ODDS (%)
Bearish Trend 1 day ago
39%
Bearish Trend 1 day ago
37%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
42%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
50%
Advances
ODDS (%)
Bullish Trend 23 days ago
43%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 1 day ago
52%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
38%
Bearish Trend 1 day ago
57%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRE92.19-0.01
-0.01%
Sempra
ACA103.18-0.40
-0.39%
Arcosa
ULH50.27-1.53
-2.95%
Universal Logistics Holdings
MESA0.88-0.06
-6.34%
Mesa Air Group
HIVE4.67-0.57
-10.88%
HIVE Digital Technologies Ltd

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with NVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-0.86%
NVS - LLY
42%
Loosely correlated
-1.01%
OGN - LLY
25%
Poorly correlated
+0.19%
JNJ - LLY
21%
Poorly correlated
+0.39%
ABBV - LLY
21%
Poorly correlated
-0.43%
PFE - LLY
20%
Poorly correlated
+2.02%
More